One of the largest studies on preterm birth finds a maternal biomarker test significantly reduces neonatal morbidities and improves neonatal outcomes
UNDER EMBARGO UNTIL: Jan. 31, 2025, 10:15 a.m. MST
Media Contact: Karen Addis, APR, karen@addispr.com, +1 (301) 787-2394
One of the Largest Studies on Preterm Birth Finds a Maternal Biomarker Test Significantly Reduces Neonatal Morbidities and Improves Neonatal Outcomes
Denver, Colo. ― Preterm birth ― defined as delivery before the 37th week of pregnancy — is one of the leading causes of infant deaths in the United States. Babies born prematurely are also at an increased risk of ...








